Vaxfab Enterprises Ltd
Vaxfab Enterprises Ltd (VEL) last reported results for the quarter ended Jun 2026, with sales of ₹0.4 crore and net profit of ₹-3.04 crore. The stock last traded at ₹64.8, a market capitalisation of ₹167 crore. Over the past 52 weeks the stock has ranged between ₹32.5 and ₹72. Figures are as of 6 Oct 2026 and are not real time.
Vaxfab Enterprises Ltd share price and key metrics
- Current price
- ₹64.8
- Market cap
- ₹167 cr
- Book value
- ₹22.3
- ROE
- -10.6%
- ROCE
- %
- Dividend yield
- 0.00%
- 52w high / low
- 72.0/32.5
Metrics as of 6 Oct 2026. Not real time.
Track Vaxfab Enterprises Ltd
Cruxal reads every Vaxfab Enterprises Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Vaxfab Enterprises Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 99%
- TTM
- 88%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -1045%
- 10 Years
- %
- 5 Years
- 46%
- 3 Years
- 55%
- 1 Year
- 100%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- -11%
Vaxfab Enterprises Ltd quarterly results
| ₹ crore | Dec 2022 | Mar 2023 | Jun 2023 | Dec 2024 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2.03 | 14.33 | 4.15 | 45.77 | 55.04 | 15.66 | 15.66 | 0.4 |
| Expenses | 1.89 | 14.03 | 3.89 | 39.41 | 54.33 | 15.33 | 15.33 | 6.05 |
| Operating profit | 0.14 | 0.3 | 0.26 | 6.36 | 0.71 | 0.33 | 0.33 | -5.65 |
| OPM % | 6.90% | 2.09% | 6.27% | 13.90% | 1.29% | 2.11% | 2.11% | -1,412.50% |
| Other income | 0 | 0.06 | 0.08 | 0.09 | -3.42 | -3.37 | -3.37 | 3.39 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0.01 | 0.04 | 0.02 | 0.03 | 0.03 | 0.02 |
| Profit before tax | 0.14 | 0.36 | 0.33 | 6.41 | -2.73 | -3.07 | -3.07 | -2.28 |
| Tax % | 28.57% | 22.22% | 18.18% | 0.00% | -16.48% | 5.21% | 5.21% | 33.77% |
| Net profit | 0.1 | 0.28 | 0.26 | 6.41 | -2.28 | -3.24 | -3.24 | -3.04 |
| EPS (₹) | 0.12 | 0.33 | 0.31 | 7.63 | -2.71 | -3.86 | -1.65 | -1.22 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Vaxfab Enterprises Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 0 | 17 | 70 | 131 | 87 |
| Operating profit | -0 | 0 | 0 | -5 | -4 |
| OPM % | -33% | 2.7% | 0.1% | -3.7% | -4.9% |
| Net profit | 0 | 0 | 0 | -5 | -12 |
| EPS (₹) | 0.00 | 0.46 | 0.58 | -2.36 | -9.44 |
TTM is the trailing twelve months to the most recent quarter.
Vaxfab Enterprises Ltd balance sheet
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2026 |
|---|---|---|---|
| Equity capital | 1 | 8 | 40 |
| Reserves | 2 | 8 | 4 |
| Borrowings | 0 | 1 | 44 |
| Other liabilities | 0 | 10 | 116 |
| Total liabilities | 3 | 27 | 204 |
| Fixed assets | 0 | 0 | 13 |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 12 | 23 |
| Other assets | 3 | 14 | 168 |
| Total assets | 3 | 27 | 204 |
As reported by the company. Total assets equal total liabilities by construction.
Vaxfab Enterprises Ltd cash flow
| ₹ crore | Mar 2022 | Mar 2023 |
|---|---|---|
| Cash from operations | -0 | 2 |
| Cash from investing | 0 | -12 |
| Cash from financing | 0 | 14 |
| Net cash flow | 0 | 4 |
| Free cash flow | -0 | 2 |
| CFO / operating profit | 178% | 418% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Vaxfab Enterprises Ltd operating ratios
| Per year | Mar 2022 | Mar 2023 | Mar 2026 |
|---|---|---|---|
| ROCE % | — | 5% | — |
| Debtor days | 1,095 | 87 | 302 |
| Inventory days | 365 | 108 | 19 |
| Days payable | 0 | 222 | 298 |
| Cash conversion cycle | 1,460 | -27 | 23 |
| Working capital days | 2,460 | 1 | 16 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Vaxfab Enterprises Ltd shareholding pattern
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|
| FIIs | 0.00% | 0.00% | 0.00% | 0.60% | 0.60% | 0.13% | 0.04% | 0.04% |
| Public | 100.00% | 100.00% | 100.00% | 99.39% | 99.41% | 99.87% | 99.96% | 99.96% |
| No. of shareholders | 2,268 | 2,737 | 2,662 | 3,017 | 2,916 | 2,974 | 2,929 | 2,929 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Vaxfab Enterprises Ltd corporate filings
- Compliances Certificate Under Regulation 74(5) of SEBI (DP) Regulation , 2018.Company Updatelow impact
- Vaxfab Enterprises Ltd announces fund raising through rights issue on October 1, 2026Company Updatelow impact
Cruxal's analysis: Vaxfab Enterprises Ltd, a small-cap company with a market cap of approximately 112 crore…
Read the full analysis - Vaxfab Enterprises Limited Approves Rights Issue of Up to Rs. 45 Crore to Raise CapitalBoard Meetinghigh impact
Cruxal's analysis: Vaxfab Enterprises Limited has announced a board-approved rights issue to raise up to Rs…
Read the full analysis - Vaxfab Enterprises Limited conducts AGM with voting results indicating strong shareholder approval for resolutions, including appointment of auditors and share capital amendmentsAGM/EGMlow impact
Cruxal's analysis: Vaxfab Enterprises Limited held its AGM on 29 September 2026 at 12:00 PM in Ahmedabad…
Read the full analysis - outcome of 43rd annual general meeting of the company held on Tuesday 29th September 2026AGM/EGMmedium impact
- Intimation for closure of trading windowInsider Trading / SASTlow impact
- Vaxfab Enterprises Limited announces board meeting to consider capital raising via equity or convertible instrumentsBoard Meetinghigh impact
Cruxal's analysis: Vaxfab Enterprises Limited has scheduled a board meeting for October 01, 2026, to…
Read the full analysis - Vaxfab Enterprises Ltd publishes routine newspaper notice for regulatory complianceCompany Updatelow impact
Cruxal's analysis: Vaxfab Enterprises Ltd has issued a newspaper publication in compliance with Regulation…
Read the full analysis - Vaxfab Enterprises Limited Announces 43rd AGM and Proposal to Increase Authorized Share Capital to INR 50 CroreAGM/EGMlow impact
Cruxal's analysis: Vaxfab Enterprises Limited has issued a notice for its 43rd Annual General Meeting…
Read the full analysis - Vaxfab Enterprises Ltd releases Annual Report for FY 2025-2026Otherslow impact
Cruxal's analysis: Vaxfab Enterprises Ltd has filed its Annual Report for the financial year 2025-2026. The…
Read the full analysis - Vaxfab Enterprises Limited Announces 43rd AGM and Proposal to Increase Authorized Share Capital to INR 50 CroreAGM/EGMhigh impact
Cruxal's analysis: Vaxfab Enterprises Limited has scheduled its 43rd Annual General Meeting for September…
Read the full analysis - Vaxfab Enterprises Limited Announces Increase in Authorized Share Capital and Schedules 43rd Annual General MeetingOthersmedium impact
Cruxal's analysis: Vaxfab Enterprises Limited has announced an increase in its authorized share capital from…
Read the full analysis - Vaxfab Enterprises Limited completes preferential warrant conversion, increasing paid-up equity capitalOthersmedium impact
Cruxal's analysis: Vaxfab Enterprises Limited has announced the allotment of 8 lakh 26 thousand 761 equity…
Read the full analysis - Vaxfab Enterprises Ltd announces allotment of equity sharesCompany Updatelow impact
Cruxal's analysis: Vaxfab Enterprises Ltd has formally announced the allotment of equity shares under…
Read the full analysis - Board Meeting Outcome for Unaudited Financial Result For The Quarter Ended On 30 June 2026Board Meetingmedium impact
- Vaxfab Enterprises Limited Reports Significant Quarterly Loss and Auditor Qualification on Financial RecordsResulthigh impact
Cruxal's analysis: Vaxfab Enterprises Limited reported a consolidated net loss of 3.04 crore for the quarter…
Read the full analysis - Vaxfab Enterprises Limited incorporates wholly owned subsidiary 'Al Rafa Enterprise FZ-LLC' in UAECompany Updatemedium impact
Cruxal's analysis: Vaxfab Enterprises Limited has announced the incorporation of a new wholly owned…
Read the full analysis - Vaxfab Enterprises Limited schedules Board Meeting for August 14, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Vaxfab Enterprises Limited has issued a formal intimation regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.